Lindsay Rosenwald
Chief Executive Officer at FORTRESS BIOTECH, INC.
Net worth: 6 M $ as of 2024-04-29
Network origin in Lindsay Rosenwald first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 30 | |
| Public Company | Pharmaceuticals: Major | 24 | |
| Public Company | Pharmaceuticals: Major | 19 | |
| Subsidiary | Pharmaceuticals: Major | 16 | |
Paramount BioCapital, Inc.
 Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States.
15
| Private Company | Investment Managers | 15 |
| Public Company | Pharmaceuticals: Major | 14 | |
Cougar Biotechnology, Inc. /Old/
 Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA.
13
| Extinct | Pharmaceuticals: Major | 13 |
| Public Company | Pharmaceuticals: Major | 10 | |
| Private Company | Financial Conglomerates | 9 | |
Caelum Biosciences, Inc.
 Caelum Biosciences, Inc. BiotechnologyHealth Technology Caelum Biosciences, Inc. operates as a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. The company was founded in January 2017 and is headquartered in New York, NY.
5
| Subsidiary | Biotechnology | 5 |
D.H. Blair & Co., Inc.
4
| Private Company | 4 | |
Helocyte, Inc.
 Helocyte, Inc. Miscellaneous Commercial ServicesCommercial Services Helocyte, Inc. engages in the development and commercialization of immunotherapies for the prevention and treatment of cytomegalovirus or CMV (cancer and infectious disease). It focuses on developing PepVax, a HLA-restricted single antigen peptide vaccine for controlling CMV in allogeneic hematopoietic stem cell transplant recipients and Triplex. The company was founded by Donald J. Diamond in 2015 and is headquartered in New York, NY.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Cyprium Therapeutics, Inc.
 Cyprium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Fortress Biotech, Inc., Cyprium Therapeutics, Inc. is an American New York-based company focused on developing novel therapies for the treatment of Menkes disease and related copper metabolism disorders. The company was granted FDA breakthrough therapy, fast track, and rare pediatric disease designations, as well as FDA orphan drug designation for both Cutx-101 and AAV-ATP7A. The European Medicines Agency also granted orphan drug designation to Cyprium. In March 2017, Cyprium entered into a cooperative research and development agreement with the Eunice Kennedy Shriver National Institute of Child Health and Human Development to advance the clinical development of Cutx-101 for the treatment of Menkes disease. In 2023, Cyprium completed the transfer of its proprietary rights and assigned its FDA documents pertaining to Cutx-101 to Sentynl Therapeutics, Inc. Cyprium and NICHD also previously entered into a worldwide, exclusive license agreement to develop and commercialize AAV-ATP7A gene therapy, which is currently in pre-clinical development. The company was founded in 2017 by Michael Sean Weiss, Lindsay Allan Rosenwald, and Lung S. Yam, who has been the CEO since then.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Baergic Bio, Inc.
 Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Baergic Bio, Inc. develops therapeutic drugs for the treatment of central nervous system disorders. It offers oncology, rare diseases, and gene therapy. The company is headquartered in New York, NY.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Cellvation, Inc.
2
| Subsidiary | 2 | |
Temple University School of Medicine
1
| College/University | Other Consumer Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Lindsay Rosenwald via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| VIOQUEST PHARMACEUTICALS, INC. | Pharmaceuticals: Other | Director/Board Member Chairman | |
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director of Finance/CFO | |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Part of Akebia Therapeutics, Inc., ACCESS Oncology, Inc. is a company that develops pharmaceutical drugs. The company is based in New York, NY. The company was founded by Michael Sean Weiss. ACCESS Oncology was acquired by Keryx Biopharmaceuticals, Inc., part of Akebia Therapeutics, Inc. from December 13, 2018 on February 06, 2004 for $36.44 million. | Pharmaceuticals: Other | Chief Executive Officer President Director of Finance/CFO | |
| GENTIUM S.P.A. (ADR) | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO | |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | Investment Managers | Founder Chairman Private Equity Investor | |
Kirax Corp.
 Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | Pharmaceuticals: Major | Founder Director/Board Member | |
Riverbank Capital Securities, Inc.
 Riverbank Capital Securities, Inc. Investment Banks/BrokersFinance Part of Two River Group Holdings LLC, Riverbank Capital Securities, Inc. deals securities. The company is based in New York, NY. | Investment Banks/Brokers | Director/Board Member Chairman | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Danube Pharmaceuticals, Inc.
 Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
| DARIOHEALTH CORP. | Medical Specialties | Director/Board Member Director/Board Member | |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Graduate Degree Graduate Degree Doctorate Degree Graduate Degree | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
| CIPLA LIMITED | Pharmaceuticals: Other | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| XTL BIOPHARMACEUTICALS LTD. | Medical Specialties | Chairman Chief Executive Officer Founder | |
| George Washington University | College/University | Undergraduate Degree Graduate Degree | |
| Orion Biomedical Fund LP | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | ||
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| Union College (New York) | College/University | Undergraduate Degree Undergraduate Degree | |
| State University of New York at Albany | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Florida | College/University | Graduate Degree Undergraduate Degree | |
| University of Maryland | College/University | Undergraduate Degree Graduate Degree | |
| Yeshiva University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Paramount BioSciences LLC
 Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Investment Managers | President General Counsel Private Equity Investor | |
Opus Point Partners Management LLC
 Opus Point Partners Management LLC Investment ManagersFinance Opus Point Partners Management LLC (OPPM) is a hedge fund manager headquartered in New York City. The firm was founded by Lindsay Rosenwald and Michael Weiss in 2009. They are owned by Opus Point Partners LLC, which is a subsidiary of Weiss & Co. LLC. OPPM manages investments that are dedicated to healthcare and life science. | Investment Managers | Founder Analyst-Equity Director of Finance/CFO | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| ARNO THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Chairman Founder | |
| CAPRICOR THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Secretary Director/Board Member Director/Board Member | |
| KITE PHARMA INC | Biotechnology | Founder Chief Executive Officer Corporate Officer/Principal | |
| Baruch College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Fordham University School of Law | College/University | Graduate Degree Graduate Degree | |
Flame Biosciences LLC
 Flame Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Flame Biosciences, Inc. operates as a biotechnology company. The firm offers research, development and commercialization of transformative therapies for cancer and other inflammatory conditions. The company was founded by Charles J. Fisher Jr., Patrick J. Scannon and Bob Stein and is headquartered in New York, NY. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
| ENTERA BIO LTD. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| DECIBEL THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Director of Finance/CFO | |
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree Doctorate Degree | |
| Two River Group Management LLC | Director/Board Member President | ||
| KRONOS BIO, INC. | Pharmaceuticals: Major | Founder Founder | |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
| NUVECTIS PHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| PUMA BIOTECHNOLOGY, INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| UROGEN PHARMA LTD. | Biotechnology | Chief Executive Officer Chairman | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Doctorate Degree | |
| PURPLE BIOTECH LTD | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer |
Statistics
International
| United States | 44 |
| Israel | 6 |
| Italy | 2 |
| India | 2 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 14 |
| Finance | 8 |
| Commercial Services | 3 |
Operational
| Director/Board Member | 352 |
| Corporate Officer/Principal | 189 |
| Independent Dir/Board Member | 99 |
| Undergraduate Degree | 82 |
| Founder | 82 |
Most connected contacts
| Insiders | |
|---|---|
| Arie Belldegrun | 42 |
| Peter Morgan Kash | 32 |
| Paul Brooke | 32 |
| Bobby Sandage | 29 |
| Malcolm Hoenlein | 28 |
| J. Lobell | 27 |
| David Tanen | 25 |
| Michael Weiss | 25 |
| Ronald Renaud | 24 |
| Neil Herskowitz | 22 |
| Morris Laster | 21 |
| Eric Rose | 21 |
| Harlan Weisman | 20 |
| Stephen Rocamboli | 20 |
| David J. Horin | 18 |
- Stock Market
- Insiders
- Lindsay Rosenwald
- Company connections
